LHC Group (NASDAQ:LHCG) Rating Increased to Buy at Zacks Investment Research

Share on StockTwits

LHC Group (NASDAQ:LHCG) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm presently has a $128.00 price objective on the health services provider’s stock. Zacks Investment Research‘s target price indicates a potential upside of 7.25% from the company’s previous close.

According to Zacks, “LHC Group, Inc. is the preferred post-acute care partner for hospitals, physicians and families nationwide. From home health and hospice care to long-term acute care and community-based services, LHC delivers high-quality, cost-effective care that empowers patients to manage their health at home. Hospitals and health systems around the country have partnered with LHC Group to deliver patient-centered care in the home. “

LHCG has been the topic of several other research reports. SunTrust Banks upped their price objective on shares of LHC Group to $130.00 and gave the company a “buy” rating in a report on Friday, March 1st. Robert W. Baird upped their price objective on shares of LHC Group from $98.00 to $120.00 and gave the company a “neutral” rating in a report on Monday, March 4th. Craig Hallum upped their price objective on shares of LHC Group from $93.00 to $114.00 and gave the company a “hold” rating in a report on Friday, March 1st. They noted that the move was a valuation call. Jefferies Financial Group upped their price objective on shares of LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, May 9th. Finally, BidaskClub upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a report on Tuesday, April 30th. Three research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. LHC Group currently has a consensus rating of “Buy” and a consensus price target of $120.42.

LHCG stock opened at $119.35 on Tuesday. The firm has a market capitalization of $3.72 billion, a P/E ratio of 33.62, a PEG ratio of 1.98 and a beta of 0.83. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21. LHC Group has a 12-month low of $80.84 and a 12-month high of $122.20.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.08. The business had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. Equities analysts anticipate that LHC Group will post 4.3 earnings per share for the current fiscal year.

In related news, COO Donald Dwayne Stelly sold 448 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $120.00, for a total value of $53,760.00. Following the sale, the chief operating officer now owns 91,252 shares in the company, valued at approximately $10,950,240. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Keith G. Myers sold 5,164 shares of the company’s stock in a transaction dated Wednesday, April 3rd. The stock was sold at an average price of $108.75, for a total transaction of $561,585.00. Following the completion of the sale, the chief executive officer now owns 96,315 shares in the company, valued at approximately $10,474,256.25. The disclosure for this sale can be found here. Insiders have sold 62,991 shares of company stock worth $7,134,055 in the last quarter. Company insiders own 5.20% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Citigroup Inc. raised its holdings in shares of LHC Group by 265.2% in the 4th quarter. Citigroup Inc. now owns 4,386 shares of the health services provider’s stock worth $412,000 after acquiring an additional 3,185 shares during the last quarter. Everence Capital Management Inc. raised its holdings in shares of LHC Group by 43.6% in the 1st quarter. Everence Capital Management Inc. now owns 4,050 shares of the health services provider’s stock worth $449,000 after acquiring an additional 1,230 shares during the last quarter. Campbell Newman Asset Management Inc. raised its holdings in shares of LHC Group by 2.4% in the 1st quarter. Campbell Newman Asset Management Inc. now owns 6,350 shares of the health services provider’s stock worth $704,000 after acquiring an additional 151 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of LHC Group in the 4th quarter worth about $695,000. Finally, Geode Capital Management LLC raised its holdings in shares of LHC Group by 6.7% in the 4th quarter. Geode Capital Management LLC now owns 325,548 shares of the health services provider’s stock worth $30,562,000 after acquiring an additional 20,482 shares during the last quarter. Institutional investors own 91.42% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Story: Discount Rate

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Fastenal  Declares $0.22 Quarterly Dividend
Fastenal Declares $0.22 Quarterly Dividend
Blackstone / Gso Loan Financing Ltd  to Issue Dividend of €0.03 on  August 23rd
Blackstone / Gso Loan Financing Ltd to Issue Dividend of €0.03 on August 23rd
City of London Investment Trust plc  to Issue Dividend of GBX 4.75 on  August 30th
City of London Investment Trust plc to Issue Dividend of GBX 4.75 on August 30th
Blue Planet Investment Trust PLC  To Go Ex-Dividend on July 25th
Blue Planet Investment Trust PLC To Go Ex-Dividend on July 25th
Cal-Maine Foods  Posts Quarterly  Earnings Results
Cal-Maine Foods Posts Quarterly Earnings Results
Cadence Bancorp  Releases  Earnings Results, Misses Expectations By $0.18 EPS
Cadence Bancorp Releases Earnings Results, Misses Expectations By $0.18 EPS


© 2006-2019 Ticker Report